| |
| |
|
| Insider
Information: |
Tyree James L |
| Relationship: |
Director |
| City: |
Abbott Park |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
286,780 |
|
|
Indirect Shares
|
1,199 |
|
|
| Direct
Value |
$15,087,459 |
|
|
|
Indirect Value
|
$125,619 |
|
|
| Total
Shares |
287,979 |
|
|
| Total
Value |
$15,213,078 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -70.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Abbott Laboratories |
ABT |
Executive Vice President |
2009-02-27 |
132,176 |
2009-02-27 |
1,199 |
Premium* |
|
|
Innoviva Inc |
INVA |
Director |
2017-04-20 |
70,554 |
2014-06-02 |
0 |
Premium* |
|
|
Chemocentryx, Inc. |
CCXI |
Director |
2022-10-20 |
0 |
2015-05-22 |
0 |
Premium* |
|
|
Assertio Holdings Inc |
ASRT |
Director |
2019-05-08 |
80,590 |
2019-05-07 |
0 |
Premium* |
|
|
Genelux Corp |
GNLX |
Director |
2023-12-13 |
3,460 |
2023-02-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
89 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2019-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,421 |
35,345 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2020-01-13 |
4 |
AS |
$36.69 |
$1,111,686 |
D/D |
(30,000) |
5,345 |
0 |
% |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2020-05-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,724 |
13,069 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2021-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,660 |
17,729 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2021-05-21 |
4 |
AS |
$9.76 |
$23,956 |
D/D |
(2,454) |
15,275 |
0 |
% |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2021-12-17 |
4 |
OE |
$12.62 |
$495,750 |
D/D |
37,500 |
52,775 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2021-12-17 |
4 |
AS |
$33.52 |
$1,313,165 |
D/D |
(37,500) |
15,275 |
0 |
% |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2022-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,726 |
23,001 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2022-06-09 |
4 |
AS |
$25.65 |
$99,129 |
D/D |
(3,863) |
19,138 |
0 |
% |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2022-08-04 |
4 |
AS |
$50.22 |
$502,200 |
D/D |
(10,000) |
9,138 |
0 |
% |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2022-10-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,138) |
0 |
0 |
- |
|
| GNLX |
Genelux Corp |
Director |
– • – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
9,000 |
0 |
- |
|
| GNLX |
Genelux Corp |
Director |
– • – |
2023-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,460 |
12,460 |
0 |
- |
|
| GNLX |
Genelux Corp |
Director |
– • – |
2023-12-13 |
4 |
S |
$12.91 |
$118,969 |
D/D |
(9,000) |
3,460 |
0 |
% |
|
89 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
